Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Large B-Cell Lymphoma-Diffuse. Found 6 abstracts

Qian L, Soderquist C, Schrank-Hacker A, Strauser H, Dupoux V, Tang CN, Smith JR, Sun A, Majumdar S, Nguyen T, Widura S, Landsburg DJ, Schuster SJ, Baxter RH, Bogusz AM. Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphoma. American journal of hematology. 2020 Mar;95(3):238-44.
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 Nov 15;123(22):4411-8.
Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK. Central nervous system prophylaxis in diffuse large B-cell lymphoma. Eur J Haematol. 2016 Aug;97(2):108-20.
Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Lee Harris N, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Lunning M, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Zafar N, Dwyer M, Sundar H. Diffuse Large B-Cell Lymphoma Version 1.2016. J Natl Compr Canc Netw. 2016 Feb;14(2):196-231.
Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Cancer. 2015 Apr;121(7):1032-9.   PMCID: PMC5531172
Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014 Feb 06;123(6):837-42.   PMCID: PMC5527396
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Large B-Cell Lymphoma-Diffuse

Large B-Cell Lymphoma-Diffuse drug therapy Middle Aged therapeutic use Female Aged Male Antineoplastic Combined Chemotherapy Protocols pathology Rituximab 80 and over Aged genetics Adult Prognosis Recurrence mortality Monoclonal Antibodies-Murine-Derived administration & dosage Treatment Outcome Follow-Up Studies Cyclophosphamide Salvage Therapy radiotherapy Hematopoietic Stem Cell Transplantation Incidence vincristine prevention & control diffuse large B-cell lymphoma early stage metabolism Proto-Oncogene Proteins c-bcl-2 Young Adult cyclophosphamide Proto-Oncogene Proteins c-myc basic helix-loop-helix (MYC) therapy Prospective Studies central nervous system relapse central nervous system involvement biosynthesis Skin Neoplasms Neoplasm Proteins Central Nervous System Neoplasms Prednisone epidemiology Chemoradiotherapy Risk Factors Chromosome Deletion doxorubicin myc Genes Program Development methods International Agencies Disease Progression adverse effects Practice Guidelines as Topic Retrospective Studies hematopoietic cell transplantation (HCT) and prednisone (R-CHOP) Cohort Studies B-Cell Lymphoma-Marginal Zone Neoplastic Gene Expression Regulation Doxorubicin Vincristine radiation Genetic Translocation MYC proto-oncogene non-Hodgkin lymphoma Neoplasm Drug Resistance Gene Rearrangement Antineoplastic Agents Neoplasm Staging Immunophenotyping Premedication Survival Rate central nervous system prophylaxis Human Chromosomes-Pair 20 Spinal Injections consolidation diffuse large B-cell lymphoma (DLBCL)
Last updated on Thursday, July 16, 2020